CSTL

NASDAQStock

Castle Biosciences, Inc.

$25.37+0.05 (+0.18%)

52-Week Range

$14.65
$43.04

Key Stats

Market Cap

754.1M

P/E Ratio

Dividend Yield

Beta

1.13

Volume

150.4K

Avg Volume

497.0K

Performance

1M

-20.63%

3M

-34.88%

6M

+17.11%

YTD

-34.30%

1Y

+31.26%

3Y

+11.79%

5Y

-61.50%

Price Chart

ETF Exposure

CSTL is held by 116 ETFs

ETFFund NameWeight
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
PreviousPage 3 of 3

About CSTL ETF Exposure

Castle Biosciences, Inc. (CSTL) is held by 116 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 754.1M, CSTL is a widely held institutional stock. The stock currently trades at $25.37. Investors can gain exposure to CSTL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CSTL, sorted by portfolio weight.